Apo-Eltrombopag 25 mg

APO-ELTROMBOPAG 25 MG tablets contain eltrombopag olamine, a medication used to support platelet production. This oral treatment is commonly prescribed for conditions affecting blood cell counts.

APO-ELTROMBOPAG 25 MG tablets are primarily used to increase platelet counts in individuals with certain blood disorders. Eltrombopag olamine works by stimulating the bone marrow to produce more platelets, which are essential for blood clotting. This medication is often considered when other treatments have not been effective or are not suitable.

Common effects of APO-ELTROMBOPAG 25 MG tablets may include headaches, nausea, and dizziness. Some individuals might experience changes in liver function or skin reactions. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

APO-ELTROMBOPAG 25 MG tablets should be handled with care, especially by individuals with liver conditions or a history of blood clots. Regular blood tests may be recommended to monitor platelet levels and liver function. Always follow the advice of a healthcare professional regarding the use of this medication.

APO-ELTROMBOPAG 25 MG tablets may interact with certain medications, including those that affect liver enzymes or blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, avoid taking this medication with products containing polyvalent cations, as they can reduce its effectiveness.